Development of a model for anemia of inflammation that is relevant to critical care
Open Access
- 25 July 2019
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine Experimental
- Vol. 7 (S1) , 1-11
Abstract
Anemia of inflammation (AI) is common in critically ill patients. Although this syndrome negatively impacts the outcome of critical illness, understanding of its pathophysiology is limited. Also, new therapies that increase iron availability for erythropoiesis during AI are upcoming. A model of AI induced by bacterial infections that are relevant for the critically ill is currently not available. This paper describes the development of an animal model for AI that is relevant for critical care research. In experiments with rats, the rats were inoculated either repeatedly or with a slow release of Streptococcus pneumoniae or Pseudomonas aeruginosa. Rats became ill, but their hemoglobin levels remained stable. The use of a higher dose of bacteria resulted in a lethal model. Then, we turned to a model with longer disease duration, using pigs that were supported by mechanical ventilation after inoculation with P. aeruginosa. The pigs became septic 12 to 24 h after inoculation, with a statistically significant decrease in mean arterial pressure and base excess, while heart rate tended to increase. Pigs needed resuscitation and vasopressor therapy to maintain a mean arterial pressure > 60 mmHg. After 72 h, the pigs developed anemia (baseline 9.9 g/dl vs. 72 h, 7.6 g/dl, p = 0.01), characterized by statistically significant decreased iron levels, decreased transferrin saturation, and increased ferritin. Hepcidin levels tended to increase and transferrin levels tended to decrease. Using pathogens commonly involved in pulmonary sepsis, AI could not be induced in rats. Conversely, in pigs, P. aeruginosa induced pulmonary sepsis with concomitant AI. This AI model can be applied to study the pathophysiology of AI in the critically ill and to investigate the effectivity and toxicity of new therapies that aim to increase iron availability.Keywords
Funding Information
- Sanquin (PPOP-14-31)
This publication has 39 references indexed in Scilit:
- Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritisArthritis Research & Therapy, 2013
- Iron Supplementation in Suckling Piglets: How to Correct Iron Deficiency Anemia without Affecting Plasma Hepcidin LevelsPLOS ONE, 2013
- The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeysBlood, 2013
- Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammationBlood, 2011
- Heparin: a potent inhibitor of hepcidin expression in vitro and in vivoBlood, 2011
- STAT6-mediated suppression of erythropoiesis in an experimental model of malarial anemiaHaematologica, 2008
- Role of iron homeostasis in trypanosomiasis-associated anemiaImmunobiology, 2008
- The severity of malarial anaemia in Plasmodium chabaudi infections of BALB/c mice is determined independently of the number of circulating parasitesMalaria Journal, 2008
- Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New GuineaMalaria Journal, 2008
- Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its InternalizationScience, 2004